克林澳联合丹红注射液治疗急性脑梗死48例疗效观察

Clinical observation of Colin Bay combined with Danhong injection on acute cerebral infarction in 48 cases

目的:观察克林澳联合丹红注射液治疗急性脑梗死的临床疗效。方法:将96例急性脑梗死患者随机分为观察组与对照组,每组各48例,对照组在常规治疗基础上给予克林澳治疗,观察组在此基础上加用丹红注射液治疗,两组疗程均为14d,治疗结束后评定疗效。结果:治疗结束后,观察组临床总有效率为89.58%,显著优于对照组的72.92%(P<0.05);观察组神经功能缺损评分改善程度显著优于对照组(P<0.05)。结论:克林澳联合丹红注射液治疗急性脑梗死的疗效确切,值得在临床进行推广。

Objective To observe the clinical efficacy of cinepazide malete combined with danhong injection for acute cerebral in- farction （ACI）. Methods 96 patients with ACI were randomly divided into observation group and control group, 48 cases in each group. The patients in the control group were treated with cinepazide malete on the basis of conventional treatment. The patients in the observation group were treated with danhong injection on the basis of the control group. The course of treatment was 14d, and the clini- cal efficacy were evaluated after the treatment. Results After treatment, the clinical total effective rate of the observation group was 89. 58%, which was significantly better than that of the control group （72.92%） （ P 〈 0. 05 ） ; the neurological deficit score of the obser- vation group improved more significantly than that of the control group （ P 〈 0.05 ）. Conclusion The method of cinepazide malete com- bined with danhong injection is effective for ACI, and has a promoted value in clinical therapy.